About the Company
at twist bioscience, our expertise is synthetic dna. we have developed a proprietary semiconductor-based synthetic dna manufacturing process featuring a 10,000-well silicon platform capable of producing synthetic biology tools, such as oligonucleotides, genes, pathways, chassis and genomes. by synthesizing dna on silicon instead of on traditional 96-well plastic plates, our platform overcomes the current inefficiencies of synthetic dna production, and enables cost-effective, rapid, high-quality and high throughput synthetic gene production. the twist bioscience platform has the potential to greatly accelerate the development of personalized medicine, sustainable chemical production, improved agriculture production as well as new applications such as in vivo diagnostics, biodetection and data storage. for more information, please visit www.twistbioscience.com .
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology
Employees
1038
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $TWST News
Twist Bioscience Launches Pangenome Spike-in Exome Panel to Enable Advancement of Research for Diverse Populations
Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality ...
Buy Rating Justified: Twist Bioscience’s Strong Demand and Strategic Expansion Signal Market Share Growth
Catherine Ramsey Schulte, an analyst from Robert W. Baird, maintained the Buy rating on Twist Bioscience (TWST – Research Report). The ...
Twist Bioscience files patent for nano-scale devices for manufacturing high-quality oligonucleotides
Discover Twist Bioscience's groundbreaking patent for nano-scale devices revolutionizing oligonucleotide manufacturing. Learn how this innovation enables rapid, precise nucleic acid library ...
Twist Bioscience Launches IVDR-compliant Precision Dx Products for Whole Exome Sequencing
Twist Precision Exome Dx Panel and Twist Precision Exome Dx Kit Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA ...
Twist Bioscience Corporation (TWST)
SOUTH SAN FRANCISCO, Calif., March 05, 2024--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its ...
Q1 2024 Twist Bioscience Corp Earnings Call
Q1 2024 Twist Bioscience Corp Earnings Call Q1 2024 Twist Bioscience Corp Earnings Call INICIO CORREO NOTICIAS FINANZAS DEPORTES CELEBRIDADES VIDA Y ESTILO MÁS... Yahoo Finanzas Iniciar sesión Correo ...
Twist Bioscience Corp.
Twist Bioscience Corp. engages in the development of a proprietary semiconductor-based synthetic DNA manufacturing process. It operates through the following geographical segments: Americas ...
Twist Bioscience Corp TWST
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Twist Bioscience Corp (0ME)
Investing.com - Twist Bioscience (NASDAQ: TWST) reported fourth quarter EPS of $-0.81, $0.11 better than the analyst estimate of $-0.92. Revenue for the quarter came in at $66.9M ...
Twist Bioscience Corp TWST
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Loading the latest forecasts...